Trial reportScientific reports2025
Ultrasound guided retrolaminar block reduces postoperative gastrointestinal system dysfunctions during percutaneous nephrolithotomy: a prospective, randomised, double-blind, clinical study.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to determine the postoperative gastrointestinal tract dysfunction and intraoperative hemodynamic effects of ultrasound-guided retrolaminar block in patients undergoing percutaneous nephrolithotomy. Fifty-eight adult patients were randomly divided into 2 groups preoperatively: Group RLB (n = 28) underwent ultrasound-guided retrolaminar block with 20 mL 0.5% bupivacaine. Group Control (n = 30) patients without block application. Primary outcome measure was abdominal Perlas score by ultrasound. Secondary outcome measures were time to first oral feeding, flatus, defecation, mobilization; duration of hospital stay; I-FEED (intake, feeling nauseated, emesis, physical examination, duration of symptoms) Score values; Patient Satisfaction Score; duration of postoperative rescue analgesia; Visual Analog Scale scores; intraoperative heart rate and mean arterial pressures. Patients in Group RLB exhibited significantly lower intraoperative opioid consumption (61.11 ± 21.18 µg, p < 0.001) and a prolonged time to rescue analgesia (13.35 ± 4.06 min). VAS scores were consistently lower postoperatively, and patient satisfaction was high. Additionally, the Group RLB demonstrated reduced gastric content volume at 6 h postoperatively (p = 0.004) and a lower I-FEED score (2.35 ± 0.91, p < 0.05), indicating improved gastrointestinal function. Heart rate and mean arterial pressure were also significantly reduced in Group RLB. Retrolaminar block has shown positive effects on postoperative pain management, gastrointestinal tract function and hemodynamic stability in PCNL. Lower opioid consumption, faster bowel movements and longer-lasting analgesic effect improved patient satisfaction and provided adequate postoperative pain control. These findings support the use of RLB as a safe and effective analgesic method in PCNL surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.